Aarti Pharma Labs Stock Screener | Share Price & Fundamental Analysis
AARTIPHARM
Pharmaceuticals
Share Price NSE
₹650.85
▼
-27.80 (-4.10%)
Share Price BSE
₹650.80
▼
-29.55 (-4.34%)
Track Aarti Pharma Labs share price live with TickJournal's free stock screener.
Analyze Aarti Pharma Labs share price history trends and compare 52-week high low
levels.
Calculate AARTIPHARM stock fair value using fundamental analysis and view live share price charts.
Determine Aarti Pharma Labs share intrinsic value and compare it with current AARTIPHARM share price.
Record your Aarti Pharma Labs trades in TickJournal's free trading journal and track your portfolio performance.
Aarti Pharma Labs Market Cap
₹6,173.53 Cr.
EPS (TTM)
₹30.06
Dividend Yield
0.71%
Debt to Equity
0.19
AARTIPHARM 52 Week High
₹964.90
Aarti Pharma Labs 52 Week Low
₹624.40
Operating Margin
23.00%
Profit Margin
10.98%
AARTIPHARM Revenue (TTM)
₹437.00
EBITDA
₹104.00
Net Income
₹48.00
Total Assets
₹2,906.00
Total Equity
₹1,990.00
Aarti Pharma Labs Share Price History - Stock Screener Chart
Screen AARTIPHARM historical share price movements with interactive charts. Analyze price trends and patterns.
Aarti Pharma Labs Company Profile - Fundamental Screener
Screen Aarti Pharma Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AARTIPHARM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0LRU01027
Aarti Pharma Labs Balance Sheet Screener
Screen AARTIPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 2,906 | 2,582 | 2,244 | 2,040 | 0 |
| Current Assets | 1,322 | 1,346 | 1,163 | 1,028 | 0 |
| Fixed Assets | 1,137 | 1,033 | 926 | 782 | 0 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 259 | 131 | 85 | 73 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 1,990 | 1,757 | 1,559 | 1,387 | 0 |
| Share Capital | 45 | 45 | 45 | 0 | 0 |
| Reserves & Surplus | 1,945 | 1,712 | 1,513 | 1,341 | 0 |
Aarti Pharma Labs Income Statement Screener - Profit & Revenue Analysis
Screen Aarti Pharma Labs income statement and profit fundamentals.
Analyze AARTIPHARM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Aarti Pharma Labs share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 437 | 418 | 388 | 562 | 543 | 463 | 558 | 508 | 450 | 441 | 459 | 486 | 472 | 532 | 457 |
| Expenses | 333 | 344 | 293 | 418 | 409 | 364 | 459 | 388 | 353 | 352 | 374 | 405 | 385 | 441 | 371 |
| EBITDA | 104 | 74 | 95 | 144 | 134 | 98 | 99 | 120 | 97 | 89 | 85 | 81 | 87 | 91 | 86 |
| Operating Profit % | 23.00% | 18.00% | 24.00% | 26.00% | 24.00% | 20.00% | 17.00% | 23.00% | 21.00% | 20.00% | 19.00% | 16.00% | 18.00% | 17.00% | 19.00% |
| Depreciation | 29 | 25 | 23 | 23 | 23 | 21 | 20 | 19 | 19 | 18 | 17 | 16 | 16 | 17 | 14 |
| Interest | 13 | 11 | 7 | 7 | 10 | 6 | 5 | 5 | 5 | 4 | 4 | 6 | 5 | 6 | 4 |
| Profit Before Tax | 63 | 39 | 65 | 115 | 101 | 72 | 74 | 96 | 74 | 67 | 64 | 59 | 65 | 69 | 68 |
| Tax | 15 | 11 | 16 | 26 | 27 | 17 | 18 | 31 | 21 | 15 | 17 | 16 | 17 | 18 | 16 |
| Net Profit | 48 | 28 | 50 | 88 | 74 | 55 | 56 | 65 | 53 | 52 | 47 | 43 | 48 | 51 | 52 |
| EPS | 5.29 | 3.08 | 5.46 | 9.75 | 8.16 | 6.03 | 6.12 | 7.20 | 5.82 | 5.72 | 5.20 | 4.73 | 5.26 | 5.64 | 5.72 |
Aarti Pharma Labs Cash Flow Screener - Liquidity Fundamentals
Screen AARTIPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | 332 | 216 | 250 | -44 | 0 |
| Investing Activities | -414 | -215 | -158 | -139 | 0 |
| Financing Activities | 65 | 10 | -164 | 260 | 0 |
| Net Cash Flow | -17 | 12 | -71 | 78 | 0 |
Aarti Pharma Labs Shareholding Pattern Screener
See Aarti Pharma Labs shareholding pattern with promoter, FII, and DII holdings.
Check Aarti Pharma Labs promoter holding and ownership changes for AARTIPHARM on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.29% | 43.72% | 42.88% | 43.10% | 46.46% | 46.46% | 46.10% | 44.66% |
| FII Holding | 7.36% | 7.35% | 8.02% | 7.68% | 8.32% | 7.06% | 7.38% | 8.64% |
| DII Holding | 7.53% | 7.80% | 6.96% | 7.66% | 9.97% | 11.47% | 11.35% | 10.36% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 34.10% | 34.43% | 35.39% | 34.85% | 29.71% | 29.57% | 29.45% | 30.39% |
| Other Holding | 6.71% | 6.69% | 6.74% | 6.70% | 5.52% | 5.43% | 5.71% | 5.94% |
| Shareholder Count | 196,314 | 187,039 | 190,655 | 184,489 | 204,122 | 189,012 | 185,436 | 185,111 |
Aarti Pharma Labs Share Dividend Screener - Share Yield Analysis
Check Aarti Pharma Labs dividend history with payout and yield data.
View Aarti Pharma Labs dividend details including ex-dates and amounts for AARTIPHARM stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹5.00 | 0.71% |
| 2024-March | ₹3.00 | 0.40% |
| 2023-March | ₹2.00 | 0.46% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Aarti Pharma Labs Stock Index Membership
See which indices include Aarti Pharma Labs stock.
Check AARTIPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Aarti Pharma Labs Market Events Screener - Corporate Actions
Get Aarti Pharma Labs corporate actions including splits, bonuses, and buybacks.
Check Aarti Pharma Labs stock events that may affect AARTIPHARM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 10.17% | ||
| Dividend | ₹ 2.50 /share | 21.02% | ||
| 2026-02-16 | 2026-02-16 | Dividend | ₹ 1.50 /share | -8.86% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | 1.87% |
| 2025-11-09 | 2025-11-09 | Quarterly Result Announcement | NA | 3.80% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -5.82% |
| 2025-05-10 | 2025-05-10 | Quarterly Result Announcement | NA | 1.53% |
| 2025-02-14 | 2025-02-14 | Dividend | ₹ 2.50 /share | 18.21% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 4.31% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -1.13% |
| 2024-08-07 | 2024-08-07 | Annual General Meeting | NA | -1.81% |
| 2024-07-31 | 2024-07-31 | Dividend | ₹ 1.00 /share | 21.96% |
| 2024-02-16 | 2024-02-19 | Dividend | ₹ 2.00 /share | -2.52% |
Aarti Pharma Labs Competitors Screener - Peer Comparison
Screen AARTIPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 433,656 | 39.41 | 54,729 | 9.71% | 10,980 | 67.71 |
| Divis Laboratories | 168,042 | 67.76 | 9,712 | 18.67% | 2,191 | 52.59 |
| Torrent Pharmaceuticals | 148,026 | 64.17 | 11,539 | 6.99% | 1,911 | 64.43 |
| Dr Reddys Laboratories | 107,417 | 19.71 | 33,741 | 16.73% | 5,725 | 53.09 |
| Cipla | 107,030 | 23.55 | 28,410 | 7.12% | 5,291 | 42.99 |
| Lupin | 105,205 | 22.95 | 22,910 | 13.74% | 3,306 | 60.69 |
| Zydus Life Science | 91,452 | 18.28 | 23,511 | 18.55% | 4,615 | 50.44 |
| Mankind Pharma | 89,302 | 50.06 | 12,744 | 20.90% | 2,007 | 52.07 |
| Aurobindo Pharma | 72,443 | 20.53 | 32,346 | 9.43% | 3,484 | 61.78 |
| Alkem Laboratories | 65,282 | 27.34 | 13,458 | 3.70% | 2,216 | 43.73 |
Aarti Pharma Labs Company Announcements - News Screener
Screen AARTIPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-02-13 | Clarification Regarding Delay In Disclosure Of Event To The Exchange | View |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-10 | Corrigendum To Intimation Of Record Date For Dividend Dated February 09 2026. | View |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-02-09 | Fixation Of Record Date For Interim Dividend | View |
| 2026-02-09 | Corporate Action-Board approves Dividend | View |
| 2026-02-09 | Financial Results For The Quarter And Nine Months Ended December 31 2025 | View |
| 2026-02-09 | Board Meeting Outcome for Outcome Of Board Meeting Held On February 9 2026 | View |
| 2026-02-06 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-29 | Board Meeting Intimation for 1. Board Meeting Intimation For Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2025 2. Declaration Of Interim Dividend If Any On The Equity Share Capital Of The Company For The Fi | View |
| 2026-01-12 | Clarification With Respect To Increase In Volume | View |
| 2026-01-12 | Clarification sought from Aarti Pharmalabs Ltd | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-22 | Closure of Trading Window | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |